—
MSD BIPOLAR Forceps ¢
510(k) Summary f age | b /
June 2006 oo
I. Company: Medtronic Sofamor Danek
1800 Pyramid Place
Memphis, TN 38132
(901) 396-3133
SEP ~5 2006
Contact: Richard W. Treharne, PhD
Vice President Regulatory Affairs
II. Proprietary Trade Name: MSD BIPOLAR Forceps
HL Classification Name: Electrosurgical Cutting and Coagulation and Accessories
IV. Regulation Number: 878.4400
Product Code: GEI
Class: Class II
Vv. Product Description
The MSD BIPOLAR Forceps are intended for use in general surgical procedures. The
device is connected through a suitable bipolar cable with the bipolar output of an
electrosurgical generator. Coagulation is achieved using electrosurgical energy generated
by the electrosurgical generator unit and activated by a footswitch.
VII Indications
The MSD BIPOLAR Forceps are designed to grasp, manipulate and coagulate selected
tissue. It is to be connected through a suitable bipolar cable with the bipolar output of an
electrosurgical generator. Bipolar Forceps must only be used with bipolar coagulation
current. The MSD BIPOLAR Forceps has not been shown to be effective for tubal
sterilization or tubal coagulation for sterilization procedures and should not be used for
these procedures.
VIII Substantial Equivalence
Documentation was provided which demonstrated the subject MSD BIPOLAR Forceps
to be substantially equivalent to the CLARIS Non-Stick Bipolar Forceps previously
cleared by the agency in K051429 (SE 07/29/05).
aaa
VIUULO

3
q RN,
f ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
oo Food and Drug Administration
9200 Corporate Boulevard
. Rockville MD 20850
SEP -5 2006
Medtronic Sofamor Danek
% Mr. Lee Grant
Supervisor, Regulatory Affairs . ‘
1800 Pyramid Place
Memphis, Tennessee 38132
Re: K061635
Trade/Device Name: MSD Bipolar Forceps
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: I]
Product Code: GEI
Dated: August 11, 2006
Received: August 15, 2006
Dear Mr. Grant:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval ofa premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{

Page 2 — Mr. Lee Grant
This letter will allow you to begin marketing your device as described in your Section 51 O(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(240) 276-3150 or at its Internet address http://www.fda.gov/cdrb/industry/support/index.html.

Sincerely yours,

Mark N. Melkerson

Director .

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

June 2006
_
510(k) Number (if known): Lol, (638
Device Name: MSD Bipolar Forceps
Indications for Use:
The MSD BIPOLAR Forceps are designed to grasp, manipulate and coagulate selected
tissue. It is to be connected through a suitable bipolar cable with the bipolar output of an
electrosurgical generator. Bipolar Forceps must only be used with bipolar coagulation
current. The MSD BIPOLAR Forceps has not been shown to be effective for tubal
sterilization or tubal coagulation for sterilization procedures and should not be used for
these procedures.
Prescription Use X_ : AND/OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF
NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Divisiolf Sign-Off) ~
Division of General, Rand Neurological Devic. .
510(k) Number_[_ oUt (36
SOGGC5

